Kim, M., Lee, J.-O., Koh, J., Kim, T. M., Lee, J. Y., Jeon, Y. K., Keam, B., Kim, D.-W., Lee, J. S. and Heo, D. S. (2021) “A phase II study of brentuximab vedotin in patients with relapsed or refractory Epstein-Barr virus-positive and CD30-positive lymphomas”, Haematologica. Pavia, Italy, 106(8), pp. 2277-2280. doi: 10.3324/haematol.2021.278301.